W. Brugger
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
-
- Cancer Cells and Metastasis
- Neutropenia and Cancer Infections
- Lung Cancer Research Studies
Papers in
- Oncology 10
- Neutropenia and Cancer Infections 4
- Cancer Treatment and Pharmacology 3
- Cancer Cells and Metastasis 2
- Colorectal Cancer Treatments and Studies 2
-
- Hematopoietic Stem Cell Transplantation 6
- Co-authors
- Lothar Kanz (10 shared papers)R Mertelsmann (3 shared papers)S Heimfeld (2 shared papers)RJ Berenson (2 shared papers)Federico Cappuzzo (3 shared papers)Ernst Dinkel (1 shared paper)Stefan Scheding (1 shared paper)Martin Halle (1 shared paper)
- Journals
- Blood (2 papers)Journal of Clinical Oncology (2 papers)Stem Cells (1 paper)Journal of Computer Assisted Tomography (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- GermanyAustriaSwitzerland
In The Last Decade
W. Brugger
16 papers receiving 454 citations
Peers
Comparison fields: 5 of 52
- Hematology 241
- Oncology 193
- Genetics 72
- Immunology 133
- Pulmonary and Respiratory Medicine 88
Countries citing papers authored by W. Brugger
This map shows the geographic impact of W. Brugger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Brugger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Brugger more than expected).
Fields of papers citing papers by W. Brugger
This network shows the impact of papers produced by W. Brugger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Brugger. The network helps show where W. Brugger may publish in the future.
Co-authors
The 25 scholars most cited alongside W. Brugger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 286 | |
| 2 | 2009 | 49 | |
| 3 | Ex vivo expansion of hematopoietic progenitor cells for clinical use. | 1998 | 28 |
| 4 | 1993 | 23 | |
| 5 | In vivo biology and therapeutic potential of hematopoietic growth factors and circulating progenitor cells. | 1992 | 21 |
| 6 | 1995 | 18 | |
| 7 | 2009 | 13 | |
| 8 | 1992 | 12 | |
| 9 | 2009 | 10 | |
| 10 | 1994 | 5 | |
| 11 | Role of hematopoietic growth factor combinations in experimental and clinical oncology. | 1992 | 5 |
| 12 | 1994 | 4 | |
| 13 | 1993 | 2 | |
| 14 | 1994 | 2 | |
| 15 | 2008 | 2 | |
| 16 | 2009 | 2 | |
| 17 | 2005 | 0 | |
| 18 | [Modification of hematotoxic effects of cyclophosphamide by anabolid steroids]. | 1975 | 0 |
About W. Brugger
W. Brugger is a scholar working on Oncology, Hematology, Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology, having authored 18 papers that have together received 482 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (6 papers), Neutropenia and Cancer Infections (4 papers), Cancer Treatment and Pharmacology (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Genomics and Diagnostics (2 papers), Cancer Cells and Metastasis (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Hematology (241 citations), Oncology (193 citations), Genetics (72 citations), Immunology (133 citations) and Pulmonary and Respiratory Medicine (88 citations). W. Brugger has collaborated with scholars based in Germany, Austria and Switzerland. Frequent co-authors include Lothar Kanz, R Mertelsmann, S Heimfeld, RJ Berenson, R Mertelsmann, Federico Cappuzzo, Ernst Dinkel, Stefan Scheding, Martin Halle and Bernhard Meister. Their work appears in journals such as Blood, Journal of Clinical Oncology, Stem Cells, Journal of Computer Assisted Tomography and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.